E1: Age-related Macular Degeneration

This episode is 10 minutes long.

This episode was published on December 9, 2020.

Peter Kaiser, MD, and Jeffrey Heier, MD, examine the findings of the Novartis-appointed Safety Review Committee’s independent assessment of post-marketing cases of inflammation following the approval of brolucizumab.

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.